Saturday, May 31, 2025
20.8 C
Bengaluru

Digital Noise to Digital Voice – A 4-Module Workshop for Pharma People

When Covid19 struck for the first time in March 2020, the pharma industry was not ready for the sudden and dramatic changes, that disrupted the healthcare industry completely.

And to deal with the sudden and dramatic changes, professionals in the pharma industry needed awareness, education, and knowledge sharing.

MedicinMan took up this responsibility in partnership with CredoWeb to create “Digital Excellence Pharma Academy” –DEPA and conducted 50+ online sessions with renowned Indian and International healthcare industry influencers as faculty members, from May 2020 to April 2021.

And DEPA1.0 was a great success!

Now is time to learn how to perform marketing and sales activities using the new technology in the New Normal on practice! 

We go into the why, how, and what of doing digital. If you were a Listener till now, you’ll be a Player now!

MedicinMan in partnership with CredoWeb is again coming up with the 2.0 version of our DEPA with international and Indian faculty – Dr. Peter Velev, a medical doctor and pharma industry veteran, Praful Akali, founder and CEO of Medulla Communications and Salil Kallianpur, pharma marketing veteran and digital brand coach.

The workshop sessions will be moderated by Anup Soans, Editor @ MedicinMan to discuss: International and Indian case studies Interactive Q & A sessions

We are launching DEPA 2.0 Workshop with four Modules beginning Saturday, October 30, 2021.

For registration and program details – https://medicinman.net/register-for-depa-2-0/

For any questions and how to join DEPA 2.0 please write to: anupsoans@medicinman.net

Hot this week

Novo Nordisk — Septerna’s $2.2 Billion Deal

A New Era for Obesity Pills Novo Nordisk has announced...

Will TATA Succeed in Reinventing Indian Pharma Retail through 1 MG Hybrid?

Tata 1mg App Business Model: How does it work...

GSK Bets Big on Liver Disease: $1.2B Upfront for Boston Pharma’s MASH Drug

In a bold move to strengthen its hepatology pipeline,...

Indian Pharma Market Performance – April 2025

The Indian Pharmaceutical Market (IPM) maintained moderate growth in...

The Future in Your Palm+Chemistry – Palmistry

The future in your palm - a non-contact wearable...

Topics

Novo Nordisk — Septerna’s $2.2 Billion Deal

A New Era for Obesity Pills Novo Nordisk has announced...

GSK Bets Big on Liver Disease: $1.2B Upfront for Boston Pharma’s MASH Drug

In a bold move to strengthen its hepatology pipeline,...

Indian Pharma Market Performance – April 2025

The Indian Pharmaceutical Market (IPM) maintained moderate growth in...

The Future in Your Palm+Chemistry – Palmistry

The future in your palm - a non-contact wearable...

Nimesulide – Nice or Not Nise?

Nimesulide Regulatory Status Worldwide Nimesulide is a non-steroidal anti-inflammatory drug...

MedicinMan Pharma Monitor March 2025

Indian Pharma Top Brands, Therapy & Regional Insights 🏆...

How Trump’s Tariff War Could Affect India’s Top 25 Pharma Companies

April 14, 2025  India’s pharmaceutical industry, a global powerhouse, sends...
spot_img

Related Articles

spot_imgspot_img